auto_awesome
Want to know who else bid on this?
ProposalForge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Entos Pharmaceuticals Inc.Amount
$62.0M
Program
SIF Stream2- GrowthProvince
ABType
Other
Agreement Number
033-2024-2025-Q4-819748
Purpose
This project will support the establishment of an innovation research and development (R&D) centre and a commercial scale, good manufacturing practices (GMP) manufacturing facility in Edmonton, Alberta for the production of novel genetic medicines.
Entos Pharmaceuticals Inc. × Innovation, Science and Economic Development Canada
1 grants totalling $62.0M
SIF Stream2- Growth
63 grants totalling $4.5B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $450.0M | SIF Stream2- Growth |
| ArcelorMittal Dofasco G.P. | $400.0M | SIF Stream2- Growth |
| Air Products Canada LTD | $300.0M | SIF Stream2- Growth |
| Cohere Inc. | $240.0M | SIF Stream2- Growth |